

Strong royalties from its migraine treatment Frovatriptan helped Vernalis narrow losses in the year to 31 December. Pre-tax losses before exceptional...


Reports that Vivendi will not be willing to pay any more than £6bn for Vodafone's 44% stake in the French mobile phone operator SFR has hit the mobile...


Wolfson Microelectronics is lower after non-executive director and co-founder Dr Alastair Milne raised £725,000 from a share disposal. Dr Milne, who...


AEA Technology has returned from suspension following the announcement of its deal to acquire Eastern Research Group Inc financed by a heavily discoun...


Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the ...


Torotrak has warned that the outcome for the year to March 2011 is still reliant on potential licence discussions and whether Allison transmission tak...


LONDON (Dow Jones)--Vernalis PLC (VER.LN), a development stage pharmaceutical company, said Thursday that it made pretax loss of GBP8.91 million for t...


By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones)--Biogen Idec Inc.'s (BIIB) move to end development of an experimental Parkinson's ...